Publication | Closed Access
Two consecutive successful live birth in woman with 17α hydroxylase deficiency by frozen–thaw embryo transfer under hormone replacement endometrium preparation
24
Citations
3
References
2017
Year
FertilityReproductive HealthGynecologyFemale Reproductive FunctionEmbryologyReproductive EndocrinologyFemale InfertilityImplantation (Embryology)Reproductive MedicineMale InfertilityPublic HealthDisorders Of Sex Development17α-Hydroxylase DeficiencyReproductive HormoneInfertilityAndrologyMaternal HealthDevelopmental EndocrinologyMaternal-fetal MedicineHydroxylase DeficiencyEndocrinologyViable EmbryoOvarian HormoneHuman ReproductionDevelopmental BiologyBp DeletionFrozen–thaw Embryo TransferUterine ReceptivityMedicineWomen's Health
17α-Hydroxylase deficiency is rare autosomal recessive disorder that manifested by hypertension, hypokalemia, delayed sexual development, primary amenorrhea and infertility. The information regarding infertility care and conception in women with this disorder are extremely limited. We report a 24-year-old Japanese woman with primary amenorrhea who was diagnosed as partial 17α-hydroxylase deficiency caused by homozygous 3 bp deletion in exon 1 of 17α-hydroxylase gene. In vitro fertilization with controlled ovarian stimulation was carried out and all viable embryo were frozen. During ovarian stimulation, serum progesterone levels were markedly elevated, and endometrial growth was impaired. Utilizing frozen-thaw embryo transfer under hormonal replacement (glucocorticoid, estradiol and progesterone), she had successfully given two consecutive live birth. Women with 17α-hydroxylase deficiency with residual ovarian reserve can afford reproductive success by appropriate diagnosis and treatment by assisted reproductive technology.
| Year | Citations | |
|---|---|---|
Page 1
Page 1